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Abstract PP2C phosphatases control biological processes including stress responses,
development, and cell division in all kingdoms of life. Diverse regulatory domains adapt PP2C
phosphatases to specific functions, but how these domains control phosphatase activity was
unknown. We present structures representing active and inactive states of the PP2C phosphatase
SpoIIE from Bacillus subtilis. Based on structural analyses and genetic and biochemical
experiments, we identify an a-helical switch that shifts a carbonyl oxygen into the active site to
coordinate a metal cofactor. Our analysis indicates that this switch is widely conserved among
PP2C family members, serving as a platform to control phosphatase activity in response to diverse
inputs. Remarkably, the switch is shared with proteasomal proteases, which we identify as
evolutionary and structural relatives of PP2C phosphatases. Although these proteases use an
unrelated catalytic mechanism, rotation of equivalent helices controls protease activity by
movement of the equivalent carbonyl oxygen into the active site.
DOI: 10.7554/eLife.26111.001
Introduction
Reversible protein phosphorylation is widely used in biological systems to control the activity of
enzymes or the association of proteins with other proteins. Kinases and phosphatases control the
phosphorylation state of target proteins in response to specific cellular or environmental cues, mak-
ing reversible phosphorylation a flexible mechanism to control diverse biological systems (Huse and
Kuriyan, 2002; Shi, 2009; Taylor and Kornev, 2011). Here we address the question of how mem-
bers of the PP2C family of serine/threonine phosphatases are regulated to control processes such as
cell growth and death, development, and responses to stress in all kingdoms of life (Kerk et al.,
2015; Lammers and Lavi, 2007; Shi, 2009). Among serine/threonine phosphatases, a distinctive
feature of the PP2C family is that the activity of a conserved catalytic domain is controlled by diverse
regulatory domains that are often linked in cis to the catalytic domain (Shi, 2009; Zhang and Shi,
2004). We investigated the PP2C family member SpoIIE, which controls the activation of the cell-
specific transcription factor sF during the developmental process of sporulation in the bacterium
Bacillus subtilis.
Sporulation involves the formation of an asymmetrically-positioned septum that divides the devel-
oping cell into large and small cellular compartments (Stragier and Losick, 1996). SpoIIE is the
most upstream member of a three-protein pathway that activates sF in the small cell (Figure 1A). It
does so by dephosphorylating the phosphoprotein SpoIIAA-P (Duncan et al., 1995).
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Dephosphorylated SpoIIAA, in turn, displaces sF from the anti-sigma factor SpoIIAB to release the
free and active transcription factor (Figure 1A) (Diederich et al., 1994). A long-standing mystery is
how SpoIIE is regulated to generate dephosphorylated SpoIIAA selectively in the small cell. Recent
work indicates that SpoIIE initially associates with the asymmetrically-positioned cytokinetic ring and
then during cytokinesis is handed off to the adjacent cell pole, which will become the small cell
(Bradshaw and Losick, 2015). Cell-specific activation is mediated by the self-association of SpoIIE
molecules in the small cell, which protects the protein from proteolysis and activates the phospha-
tase (Bradshaw and Losick, 2015). Here we focus on the molecular mechanism of phosphatase
activation.
Like other PP2C family phosphatases, the catalytic center of SpoIIE uses two divalent cations
(manganese in the case of SpoIIE) to deprotonate a water molecule that serves as the nucleophile
for dephosphorylation (Arigoni et al., 1996; Schroeter et al., 1999). This active site is embedded in
the conserved fold of the PP2C domain, which is shared by all PP2C family members (Shi, 2009).
The PP2C domain is paired with diverse regulatory modules (over 1500 unique domain architectures
have been identified in the InterPro database) (Mitchell et al., 2015), but how these regulatory mod-
ules control phosphatase activity was not understood. Here we identify a pair of a-helices at the
heart of the regulatory mechanism that rotate to position a carbonyl oxygen to bind an active site
Mn2+ ion and activate SpoIIE. We present evidence that this mechanism is widely conserved among
PP2C family members. Remarkably, rotation of equivalent a-helices is also used to control an unre-
lated catalytic mechanism in the structurally similar family of enzymes that form the catalytic core of
the proteasome (Arciniega et al., 2014; Ruschak and Kay, 2012; Shi and Kay, 2014; Sousa et al.,
2000). This raises the possibility that PP2C phosphatases and proteasome proteases have a common
evolutionary history that is linked by a shared regulatory mechanism.
eLife digest To regulate the activity of proteins, cells often modify them by adding or removing
chemical groups called phosphates. Therefore, the enzymes that add or remove these phosphate
groups must be tightly regulated so that they are active at the right time and place. Enzymes known
as phosphatases remove phosphate groups from proteins and the PP2Cs are one such family of
enzymes that are found in bacteria, plants and animals. Despite their broad importance, it was not
clear how cells control the PP2Cs.
One way to understand how an enzyme is controlled is to compare the three-dimensional
structures of the enzyme when it is active and when it is inactive. Bradshaw et al. used a PP2C
enzyme from bacteria as a model to understand how the cell regulates other PP2Cs.
The experiments reveal that the bacterial enzyme has a structural element that acts as a switch to
control its activity. The phosphatase needs to bind metal ions to be active, and movement of the
switch promotes binding of the metal ions to activate the phosphatase. The switch is also found in
other members of the PP2C family. Furthermore, members of a seemingly unrelated family of
enzymes called the proteasomal proteases, which degrade proteins, also have a similar architecture
and are controlled by a similar switch. Thus, the phosphatase and protease families may have a
common evolutionary history.
Multiple members of the PP2C family are involved in cancer and other diseases. The discovery of
a regulatory switch provides new opportunities to use drugs to control phosphatase activity in
patients. Many cancer drugs that are currently in use or are under development target enzymes that
add phosphate groups to proteins, but efforts to target the phosphatases have largely been
unsuccessful. Bradshaw et al.’s findings may enable the development of new drugs that target
protein phosphatases.
DOI: 10.7554/eLife.26111.002
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Figure 1. The structure of SpoIIE with its regulatory domain. A is a diagram of the three-protein pathway controlling sF. B is a schematic diagram of the
SpoIIE primary structure with its N-terminal cytoplasmic degradation tag in black, the 10 transmembrane segments in dark grey, the regulatory domain
in blue, and the PP2C phosphatase domain shown in light grey. Also shown are the switch helices in orange and the metal-coordinating residues within
the active site in red. The black box identifies the SpoIIE457-827 fragment that was crystallized. C is a ribbon diagram of a single molecule of SpoIIE457-
827 with front and side views using the same color scheme as the diagram in panel B. The inset shows the putative metal coordinating sidechains of the
active site (from top to bottom: D795, D746, and D628) and the backbone carbonyl of G629. Figure 1—figure supplement 1 shows the 2Fo-Fc electron
density map and a stereo representation of the SpoIIE457-827 structure. D shows the dimer observed in the crystal structure of SpoIIE457-827 (chains A and
B) with the two protomers in darker and lighter shades (buried surface area 1500–2000 A˚2 per monomer). The two and a half dimers in the asymmetric
unit are shown in Figure 1—figure supplement 2.
DOI: 10.7554/eLife.26111.003
The following figure supplements are available for figure 1:
Figure supplement 1. Validation of the SpoIIE457–827 structure.
DOI: 10.7554/eLife.26111.004
Figure supplement 2. The crystal lattice contains three similar SpoIIE dimers.
DOI: 10.7554/eLife.26111.005
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Results
Overview
To investigate how PP2C phosphatase activity is regulated, we sought to determine X-ray crystal
structures of SpoIIE with the phosphatase in the active and inactive states. We present a structure of
a fragment that includes the entire PP2C phosphatase domain and a portion of the adjacent regula-
tory domain. This structure shows that the regulatory domain mediates the formation of dimers
between SpoIIE molecules, and evidence indicates that dimerization is needed to activate the phos-
phatase. We also present a structure of the phosphatase domain alone. A comparison of the struc-
tures reveals that dimerization rotates two a-helices of the PP2C fold (a1 and a2 of the conserved
PP2C fold) (Das et al., 1996) relative to the phosphatase core. We refer to these helices as switch
helices and present evidence that this shift in position switches the phosphatase from the inactive to
active state.
Structure of the phosphatase domain with a portion of the adjacent
regulatory domain
To determine how SpoIIE is regulated, we first sought to determine the structure of the molecule in
an active, self-associated state. The entire, 270-residue-long regulatory domain mediated the forma-
tion of heterogeneous multimers that were refractory to crystallization (Bradshaw and Losick,
2015). Using bioinformatic analysis, we devised a construct (SpoIIE457–827) that included the C-termi-
nal half of the regulatory domain and the PP2C phosphatase domain (Figure 1B; information on the
design of the construct is presented in the Materials and methods). This construct produced mono-
disperse protein that yielded crystals. Despite limited (3.9 A˚) resolution of the diffraction data, the
overall secondary structure elements were well-defined in electron density maps for both the regula-
tory and the phosphatase domains (Figure 1, Figure 1—figure supplement 1, and Table 1). The
most striking feature of the regulatory domain was an N-terminal 45-residue long a-helix (residues
473–518) that makes intramolecular contacts with the switch helices (a1 and a2) of the phosphatase
domain (Figure 1C).
The five molecules of SpoIIE457-827 in the asymmetric unit were paired in similar dimers; two
dimers were formed within the asymmetric unit and the fifth molecule dimerized across a crystallo-
graphic two-fold axis (Figure 1D, Figure 1—figure supplement 2). The core of the dimer interface
(1500–2000 A˚2 buried surface per monomer) was formed from antiparallel contacts between the
long a-helices from the regulatory domains of adjacent molecules. Additionally, the switch helices at
the base of each phosphatase domain contact each other across the dimer interface (Figure 1,
Figure 2A and B, shown in orange).
Amino acid substitutions in the dimer interface block function
To investigate the role of dimerization in stabilization, localization and phosphatase activation, we
systematically created substitutions of residues that make up the dimer interface and investigated
the ability of these mutants to function during sporulation. We substituted the native amino-acids
with lysine because the positive charge and the long side chain would be expected to impair dimer-
ization. The effect of these substitutions on stabilization and subcellular localization was investigated
by use of a SpoIIE-YFP fusion and the effect on phosphatase activity was judged by use of a sF-
dependent reporter (Figure 2B, red circles, Figure 2—figure supplement 1A,B and C). The results
revealed that a continuous region of the dimer interface (marked with red circles in Figure 2B) com-
posed of six residues from the long a-helix of the regulatory domain (V480, L484, V487, M491,
F494, and I498) and three residues from the switch helices (L646, I650, and T663) were needed for
all three aspects of SpoIIE function. These findings are consistent with the hypothesis that the dimers
observed in our structure represent the active state of the phosphatase.
Structure of the phosphatase domain
To investigate how dimerization activates phosphatase activity, we sought to compare the active
dimeric structure of SpoIIE457–827 to inactive SpoIIE. Previously, we determined the structure of
SpoIIE590–827, a fragment that included the PP2C phosphatase domain but lacked the adjacent regu-
latory domain (Levdikov et al., 2012). We hypothesized that this structure represented the inactive
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state because it lacked the dimeric interface of the SpoIIE457–827 structure. Although monomeric in
solution under physiological conditions, SpoIIE590–827 had undergone a domain-swap dimerization
during crystallization (Levdikov et al., 2012). Here, we solved an additional structure for SpoIIE590–
827 (with an amino acid substitution A624I that was designed to block domain swapping) that was in
a different crystal form and was not domain-swapped (Figure 3A). Importantly, the only significant
differences between the two SpoIIE590–827 structures were at the site of the domain-swap (Figure 3—
Table 1. Data collection and refinement statistics.
SpoIIE457-827 (5UCG) SpoIIE590-827 (5MQH)
Data collection
Beam source APS 24-ID-C Diamond, I02
Wavelength (A˚) 0.9792 0.97950
Space group P43212 C2221
Cell dimensions
a, b, c (A˚) 125.62, 125.62, 330.70 56.29, 122.51, 81.62
a, b, g (˚) 90, 90, 90 90, 90, 90
Resolution (A˚)* 60–3.9 (3.97–3.9) 61.34–2.44 (2.48–2.44)
Total reflections* 284918 (8031) 60359 (4228)
Unique reflections* 24917 (1181) 10961 (681)
Rsym
†* 0.102 (1.448) 0.057 (0.631)
CC1/2 0.999 (0.847) 0.999 (0.874)
CC* 1.00 (0.958) -
I / sI* 24.7 (0.8) 20.1 (2.8)
Completeness (%)* 99.7 (97.4) 99.7 (99.8)
Redundancy* 11.4 (6.8) 6.3 (6.2)
Refinement
Resolution (A˚)* 50–3.9 (4.1–3.9) 50–2.45 (2.51–2.45)
No. reflections 21558 10187
Rwork / Rfree
‡* 0.28/0.32 0.21/0.28
No. atoms
Protein 13166 1783
B-factors
Protein 93.0 68.0
R.m.s. deviations
Bond lengths (A˚) 0.002 0.010
Bond angles (˚) 0.525 1.545
Ramachandran plot
Favored (%) 92.48 96.9
Allowed (%) 7.40 3.1
Outliers (%) 0.12 0
Rotamer outliers (%) 6.44 15.4
*Values in parentheses are for highest-resolution shell.
†Rsym =
P
hkl
P
i|Ii - <I> |/
P
hkl
P
i <I> where Ii is the intensity of the ith measurement of a reflection with indexes hkl
and <I> is the statistically weighted average reflection intensity.
‡Rwork =
P
||Fo| - |Fc||/
P
|Fo| where Fo and Fc are the observed and calculated structure factor amplitudes, respec-
tively. Rfree is the R-factor calculated with 5% of the reflections chosen at random and omitted from refinement.
DOI: 10.7554/eLife.26111.006
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Figure 2. Dimerization activates the phosphatase. A is a surface representation of the SpoIIE457–827 dimer with the phosphatase domain, the switch,
and the regulatory domain color coded as indicated in the associated schematic. Chain A is colored with darker shades and Chain B is colored with
lighter shades. B is an open-book view of the SpoIIE457–827 dimer with the interface (defined as residues within 4.5 A˚ of the adjacent molecule) outlined
in black. Red circles mark positions of amino-acid substitutions that blocked stabilization, localization, and activation (V480K, L484K, V487K, M491K,
F494K, I498K, L646K, I650K, and T663K), whereas white circles mark positions of substitutions that blocked activation (as judged by sF activity) but not
stabilization and localization (E639K, E642K, and I667K). Figure 2—figure supplement 1 presents the analysis of the behavior of the SpoIIE mutants in
vivo. C is a surface representation of Chain A of SpoIIE457-827 rotated approximately 180˚ relative to the dimeric view in A. White circles indicate
positions of substitutions that led to defects in activation (but not localization) of SpoIIE in vivo (Q483A, G486K, V490K, and E497K). The box outlines
the section of the long a-helix of the regulatory domain that is represented as a helical wheel in D. Figure 2—figure supplement 1 presents the
analysis of the behavior of the SpoIIE mutants in vivo. D is a helical wheel representation of residues 480 to 498 from the long a-helix of the regulatory
domain. Positions at which substitutions led to defects in sF activation are indicated by circles colored as in B and C. Black text (A481K, S488K, D493K,
and S495K) indicates positions where substitutions did not lead to a phenotype, grey text represents positions that were not tested. Figure 2—figure
supplement 1 presents the analysis of the behavior of the SpoIIE mutants in vivo.
DOI: 10.7554/eLife.26111.007
The following figure supplement is available for figure 2:
Figure supplement 1. Functional analysis of the dimer interface.
DOI: 10.7554/eLife.26111.008
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Figure 3. Repositioning the switch activates the phosphatase. A is a ribbon diagram of the structure of SpoIIE590–
827, which is the phosphatase domain of SpoIIE lacking the regulatory domain. The region of the protein that was
crystallized is diagramed above. The switch region and Mn2+-coordinating residues are color-coded as in
Figure 1A. Figure 3—figure supplement 1 shows a comparison with the previously published domain swapped
SpoIIE590–827 structure. B compares the conformations of the phosphatase domain in the dimeric SpoIIE457–827
structure (switch helices in dark orange) and the isolated phosphatase domain of SpoIIE590–827 (switch helices in
light orange). The structures were aligned based on the core of the phosphatase domain excluding the switch
region (residues 590–628 and 678–827) with an RMSD = 0.952 A˚ (970 to 970 atoms). The major conformational
change upon dimerization corresponds to a rotation and upward movement of the switch helices. Figure 3—
figure supplement 2 shows how gain of function mutants may promote the conformational change. C is a model
for how rotation of the switch helices leads to phosphatase activation. In the inactive state (left) G629 is not
positioned to coordinate the M2 metal. We propose that dimerization (right) leads to rotation of the switch helices
(orange), which repositions G629 to recruit manganese and complete the active site. We note that an additional
glycine of RsbX (G47), corresponding to G631 of SpoIIE, also coordinates M2. Thus, it is possible that G631 also
Figure 3 continued on next page
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figure supplement 1). Also, contacts between the phosphatase domains observed in the SpoIIE457–
827 dimer were not present in either of the SpoIIE590–827 structures.
Comparison of the SpoIIE590–827 structures with SpoIIE457–827 revealed that dimerization rotated
the switch helices (a1 and a2 of the PP2C fold, corresponding to SpoIIE residues 630–678) approxi-
mately 45˚ as a rigid body relative to the phosphatase core (Figure 3B, Video 1). We hypothesized
that this conformational change of the switch helices is responsible for activation of the SpoIIE
phosphatase.
Repositioning the switch region is necessary for phosphatase activation
To evaluate whether repositioning of the switch region is responsible for phosphatase activation, we
returned to our genetic analysis of the contacts made in the SpoIIE457–827 structure. In the dimer, the
switch helices are held in position by intramolecular contacts with the long a-helix of the regulatory
domain and intermolecular contacts between switch helices across the dimer interface (Figures 1D,
2B and C). We found that single-amino acid substitutions at either of these contact sites blocked
phosphatase activity but not stabilization or localization to the small cell. Phosphatase activity was
assessed by sF-directed gene expression and
stabilization and localization by use of a SpoIIE-
YFP fusion (white circles in Figure 2C and D and
Figure 2—figure supplement 1A and D). This
result defines two roles for the long a-helix: one
face of the helix mediates dimerization and is
required for all three aspects of SpoIIE function
(stabilization, localization and phosphatase activ-
ity) (Figure 2B and D red circles), and the other
face, which makes intramolecular contacts with
the switch region, is specifically required for
phosphatase activity (Figure 2B–D white circles).
Additionally, these results are consistent with the
idea that dimerization stimulates phosphatase
activity by repositioning the switch helices.
Evidence from gain-of-function
mutants that repositioning the
switch helices is sufficient for
phosphatase activation
Replacement of valine at position 697 with ala-
nine causes a gain-of-function mutant phenotype
in which sF is activated constitutively
(Carniol et al., 2004; Hilbert and Piggot,
2003). The V697A substitution also enhanced
phosphatase activity as measured in vitro
(Bradshaw and Losick, 2015). But how this
Figure 3 continued
coordinates M2 in place of the lower right-hand water molecule depicted in the schematic diagram (Teh et al.,
2015). Figure 3—figure supplement 3 shows details of the active site in the SpoIIE457–827 structure.
DOI: 10.7554/eLife.26111.009
The following figure supplements are available for figure 3:
Figure supplement 1. Comparison of the SpoIIE590–827 structures.
DOI: 10.7554/eLife.26111.010
Figure supplement 2. Gain-of-function alleles activate the phosphatase.
DOI: 10.7554/eLife.26111.011
Figure supplement 3. Manganese binding in the SpoIIE active site.
DOI: 10.7554/eLife.26111.012
Video 1. The PP2C phosphatase domain of SpoIIE
changes conformation upon dimerization. Shown is the
PP2C phosphatase domain of SpoIIE (switch helices in
orange) morphing from the structure of SpoIIE590–827 to
the structure of SpoIIE457–827. The structures were
aligned based on the core of the phosphatase domain
excluding the switch region (residues 590–628 and 678–
827) as in Figure 3B.
DOI: 10.7554/eLife.26111.013
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substitution acts had been unclear. Our structure of SpoIIE590–827 reveals that in the monomeric
state, V697 packs in a hydrophobic pocket between the b strands at the base of the PP2C domain
and the switch (Figure 3—figure supplement 2A). In contrast, N665 from the switch packs near
V697 in the structure of SpoIIE457–827 in the dimeric state. We therefore hypothesize that in the wild
type, V697 stabilizes the conformation of the switch helices in the inactive monomeric state and that
truncating V697 to alanine stabilizes the active conformation by promoting solvation of the polar res-
idue N665 (Figure 3—figure supplement 2A). Thus, and according to our hypothesis, replacing
V697 with alanine destabilizes the inactive state by removing hydrophobic contacts and favors the
active conformation by eliminating a repulsive interaction. Reinforcing this hypothesis, substitution
of V697 with a bulky hydrophobic residue (phenylalanine), which could similarly destabilize the inac-
tive conformation, also causes constitutive activity (Bradshaw and Losick, 2015).
Other gain-of-function mutants that stimulate phosphatase activity in the context of a loss-of-
function mutant support this hypothesis (Carniol et al., 2004). The amino acid substitutions in these
mutants (L479F, K649T, I650L, I684V, L695W, and V728M) were all located at positions in the struc-
ture that could contribute to positioning the switch helices (Figure 3—figure supplement 2B). I684
and L695 project down from the b-strands at the base of the phosphatase domain to contact the
switch. K649 and I650 are themselves part of the switch helices and project across the dimer inter-
face. V728 projects towards the switch from the loop implicated in substrate binding in other PP2C
phosphatases. Finally, L479 projects up towards the switch from the long a-helix of the regulatory
domain. We conclude that, like V697A, these amino-acid substitutions bias the phosphatase domain
to the active conformation of the switch region.
The switch helices move a conserved manganese-coordinating residue
into the active site
How does repositioning the switch region activate phosphatase activity? All PP2C phosphatases
coordinate 2–3 divalent metals (usually manganese) in their active sites (Das et al., 1996; Shi, 2009).
The two core metal ions, known as M1 and M2, directly participate in catalysis by deprotonating a
water molecule that serves as the nucleophile for hydrolysis (Das et al., 1996). Based on the univer-
sally conserved architecture of the catalytic center, the M2 metal of SpoIIE is predicted to be coordi-
nated by the side-chain of D628 and the carbonyl oxygen of G629 (Schroeter et al., 1999)
(Figure 1C and Figure 3C). G629 is at the junction between the switch helices and the b strands at
the base of the phosphatase domain, such that movement of the switch helices could be coupled
with bringing G629 into position to recruit M2.
In support of this idea, G629 is not in position to coordinate M2 in our isolated phosphatase
domain structures, which we thus conclude represent an inactive state. This is supported by the fact
that although our previously published structures included manganese in the crystallization condi-
tions, the M2 site was unoccupied and the active site contained only a single manganese
(Levdikov et al., 2012). While soaking SpoIIE457–827 crystals with manganese degraded the diffrac-
tion, an anomalous difference map provided evidence that manganese was bound in the active site
(Figure 3—figure supplement 3A and Table 2). Due to the low (5.4 A˚) resolution of the data for the
manganese-soaked crystals, the number of bound metal ions and their position in the active site
could not be established. In the dimeric SpoIIE457–827 structure and in contrast to the SpoIIE590–827
structure, the loop connecting the switch helices to G629 was ordered (Figure 3—figure supple-
ment 3B) and overlaid well with M2-containing structures of closely related phosphatases such as B.
subtilis RsbX (Teh et al., 2015), M. tuberculosis Rv1364c (King-Scott et al., 2011), and S. thermophi-
lus Sthe_0969 (Nocek et al., 2010) (Figure 3—figure supplement 3C). We propose that the shift of
the switch helices activates the phosphatase by repositioning G629 to recruit M2 and complete the
active site (Figure 3C).
Mn2+ stimulates dimerization and phosphatase activity
A prediction of the hypothesis that movement of the helices allows recruitment of M2 is that binding
of metal to the active site of SpoIIE should be coupled to dimerization and activation. Whereas in
cells, cues in the forespore promote self-association of SpoIIE to induce phosphatase activity
(Bradshaw and Losick, 2015), we reasoned that in vitro, in the absence of cellular cues, addition of
high concentrations of manganese should drive dimerization and activation by mass action
Bradshaw et al. eLife 2017;6:e26111. DOI: 10.7554/eLife.26111 9 of 23
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(Figure 4A). We used size exclusion chromatography coupled to multi angle laser light scattering
(SEC-MALLS) to monitor SpoIIE dimerization over a range of manganese concentrations. In the
absence of manganese, SpoIIE457–827 eluted as a single monodisperse peak with a calculated molec-
ular weight of 42 kDa, consistent with the calculated molecular weight of a monomer (Figure 4B).
Addition of 250 mM and 1 mM MnCl2 induced dimerization of SpoIIE
457–827, shifting and broadening
the peak in concert with an increase in molecular mass (Figure 4B). In support of the idea that this
dimerization uses the interface found in the SpoIIE457–827 structure, substitution of a residue from
the interface (L484) with lysine blocked dimerization even after addition of 1 mM MnCl2 (Figure 2,
Figure 4—figure supplement 1). Additionally, substitution of the M2 coordinating residue D628
with alanine partially impaired dimerization in the presence of 1 mM MnCl2, suggesting that manga-
nese binding in the active site promoted dimerization (Figure 4—figure supplement 1).
To test whether manganese-induced dimerization correlated with phosphatase activation, we
measured the dependence of phosphatase activity on manganese concentration using an assay for
dephosphorylation of SpoIIAA-P, the native substrate of SpoIIE. By varying the manganese concen-
tration in the presence of saturating substrate, we determined that SpoIIE was cooperatively acti-
vated (h = 2.0) with a K1/2 for manganese of 0.56 mM (Figure 4C). This correlates well with the
manganese dependence of dimerization (Figure 4B left panel). Additionally, cooperative activation
with a Hill coefficient of two indicates that at least two manganese ions bind in the active site of
SpoIIE, consistent with the proposed catalytic mechanism (Figure 3C).
Our hypothesis also predicts that the V697A substitution would reduce the manganese concen-
tration required for dimerization and phosphatase activity by favoring the active conformation of the
switch. Indeed, the K1/2 for manganese was reduced from 0.56 mM to 0.13 mM for SpoIIE
V697A
(Figure 4C), and SEC-MALLS revealed that the V697A substitution similarly reduced the concentra-
tions of manganese required to promote dimer formation (Figure 4B right panel). Together these
experiments provide biochemical evidence that SpoIIE dimerization is coupled to phosphatase activ-
ity by rotation of the switch region and coordination of manganese in the active site.
Table 2. Data collection statistics for anomalous datasets.
SpoIIE457-827
Mn
SpoIIE457-827
SeMet
Data collection
Beam source APS 24-ID-C APS 24-ID-E
Space group P43212 P43212
Cell dimensions
a, b, c (A˚) 124.783, 124.783, 329.787 123.081, 123.081, 329.556
a, b, g (˚) 90, 90, 90 90, 90, 90
Inflection Inflection
Wavelength (A˚) 1.89350 0.97920
Resolution (A˚)* 50–5.4 (5.49 — 5.4) 50–5.7 (5.8–5.7)
Total reflections* 40325 (318) 51233 (4024)
Unique reflections* 8598 (187) 8071 (706)
Rsym* 0.145 (0.535) 0.175 (1.475)
CC1/2* 0.99 (0.75) 0.996 (0.459)
CC* * 0.997 (0.926) 0.999 (0.793)
Mean I / sI* 9.14 (1.00) 7.86 (1.13)
Completeness (%)* 90.1 (41.6) 99.0 (97.4)
Redundancy* 4.7 (1.7) 6.3 (5.7)
*Values in parentheses are for highest-resolution shell.
DOI: 10.7554/eLife.26111.014
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Discussion
We have presented the structures of the active and inactive state of the PP2C phosphatase SpoIIE
from B. subtilis. Based on these structures, analysis of the function of SpoIIE mutants in vivo, and bio-
chemical experiments, we propose that the movement of two helices at the base of the phosphatase
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Figure 4. The switch promotes manganese binding in the phosphatase active site. A is a model for phosphatase activation. During sporulation, cellular
cues induce dimerization of SpoIIE molecules, rotating the switch helices and leading to Mn2+ binding in the active site. A prediction of this model is
that high concentrations of Mn2+ would drive SpoIIE to become activated and form dimers. B shows SEC-MALLS (size exclusion chromatography
coupled to multi angle laser light scattering) results for the SpoIIE457-827 fragment to assess complex formation at various concentrations of Mn2+. The
top plot shows molecular weights calculated from light scattering and the bottom plot shows the corresponding UV absorbance traces for both wild-
type SpoIIE (left-hand side) and the gain-of-function mutant SpoIIEV697A (right). The experiments were performed in the absence of Mn2+ (grey), with
0.25 mM MnCl2 (light purple), and at 1 mM MnCl2 (purple). All experiments were performed in triplicate and data from representative runs are shown.
Figure 4—figure supplement 1 shows size exclusion chromatography analysis of additional SpoIIE mutants. The source data are included as
Figure 4—source data 1. C is a plot of phosphatase activity (initial rates, vobs) for the wild-type (black) and V697A mutant (purple) SpoIIE
457–827
fragments as a function of MnCl2 concentration using SpoIIAA-P as the substrate. The data were fit with the equation vobs=Vmax*[MnCl2]
h/(K+[MnCl2]
h)
where h is the Hill coefficient calculated from the inset panel [Vmax = 4.15 ± 0.04 min
–1 (2.28 ± 0.04 min–1 for SpoIIEV697A) and K = 0.32 ± 0.02 mM
(0.020 ± 0.002 mM for SpoIIEV697A)]. The K1/2 values reported in the text were calculated from this equation and represent the concentration of MnCl2 at
which SpoIIE has half maximal activity. Inset is a Hill plot for data points representing 10–90% activity. Lines are linear fits to the data using the equation
log(vobs/(Vmax–vobs))=h*log[MnCl2]–logK [h = 2.0 ± 0.1 (1.92 ± 0.1 for SpoIIE
V697A) and K = 0.31 ± 0.04 mM (0.022 ± 0.008 mM for SpoIIEV697A)]. The
reported error is the error of the fit to the data. Experiments were repeated at least three times and data from a representative experiment are shown.
The source data are included as Figure 4—source data 1.
DOI: 10.7554/eLife.26111.015
The following source data and figure supplement are available for figure 4:
Source data 1. Source data for Figure 4B and C.
DOI: 10.7554/eLife.26111.016
Figure supplement 1. Manganese-induced dimerization requires the active site and dimer interface.
DOI: 10.7554/eLife.26111.017
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domain, forming the switch region, activates the phosphatase by positioning the carbonyl oxygen of
a conserved glycine to coordinate manganese in the active site. Importantly, and as we will explain,
structural and functional data additionally suggest that the switch mechanism is broadly conserved
among PP2C phosphatases. Unexpectedly, and underscoring the flexibility and conservation of the
switch, our analysis also reveals that a similar module controls the activity of proteases that form the
catalytic core of the proteasome. This raises the possibility that the switch helices are a shared, and
possibly evolutionarily conserved, feature of at least two families of enzymes that use unrelated cata-
lytic mechanisms.
The SpoIIE regulatory switch is broadly conserved among PP2C
phosphatases
The following illustrative examples highlight the conservation and adaptability of the allosteric regu-
latory mechanism among PP2C phosphatases (Figure 5):
RsbP
The phosphatase RsbP from B. subtilis is activated in response to energy stress by binding to its
partner (RsbQ) to activate the transcription factor sB (Vijay et al., 2000) (Figure 5—figure supple-
ment 1A). Gain-of-function mutants of RsbP that constitutively activate sB in the absence of RsbQ
identified two elements in RsbP that control PP2C phosphatase activity (Brody et al., 2009). One
element corresponds to one of the two switch helices we identified for SpoIIE (a1). The other ele-
ment (designated as a0 by Brody et al.) was from the RsbP regulatory domain, and comparison with
the structure of a closely related phosphatase (Levchenko et al., 2009) (RssB; the structure of RsbP
itself has not been solved) suggests that this helix contacts the switch (Figure 5—figure supplement
1B). This suggests that RsbP and related phosphatases use the a0 helix as a regulatory module to
position the switch to control phosphatase activity. This supports the broad conservation of the
switch mechanism and suggests that the switch is controlled by docking varied input domains with
the switch helices.
Pdp1
Pyruvate dehydrogenase phosphatase (Pdp1) dephosphorylates pyruvate dehydrogenase to pro-
mote respiratory metabolism (Vassylyev and Symersky, 2007) (Figure 5—figure supplement 2A).
Human Pdp1 activity is inhibited by phosphorylation at a site distant from the active site (Y94), and
phosphorylation at Y94 is commonly observed in human cancer cells and contributes to the Warburg
effect (Shan et al., 2014). In the Pdp1 structure Y94 contacts a structural motif unique to Pdp1
(Vassylyev and Symersky, 2007) that packs against a pair of a-helices structurally homologous to
the SpoIIE switch helices (Figure 5—figure supplement 2B). We hypothesize that phosphorylation
of Y94 would displace this structural element, shifting the position of the switch helices and inhibit-
ing Pdp1 activity through a mechanism similar to that for SpoIIE regulation. Additionally, Pdp1 is
activated by binding to the lipoyl moiety on the E2 subunit of the pyruvate dehydrogenase complex,
and the proposed lipoic acid binding site is contained in the same structural element that is con-
tacted by Y94 and packs against the switch helices (Vassylyev and Symersky, 2007) (Figure 5—fig-
ure supplement 2B). Thus, our model for PP2C regulation may explain how Pdp1 integrates both
positive and negative regulatory signals to control phosphatase activity.
Fem-2
The C. elegans Fem-2 phosphatase regulates sex determination in complex with its regulatory part-
ners Fem-1 and Fem-3 (Chin-Sang and Spence, 1996) (Figure 5—figure supplement 3A). Addition-
ally, the mammalian homologue of Fem-2 promotes caspase-dependent apoptosis by antagonizing
Ca2+/calmodulin-dependent protein kinase (Tan et al., 2001). Fem-2 has a specific N-terminal regu-
latory domain that is the scaffold for binding Fem-1 and Fem-3 to form the active complex
(Zhang et al., 2013). In the Fem-2 structure this regulatory domain packs against the equivalent of
the switch helices (Zhang et al., 2013) (Figure 5—figure supplement 3B). How Fem-2 phosphatase
activity is regulated is not clear, but the direct contact between the Fem-2 regulatory domain and
the switch helices is consistent with our proposed model for regulation of phosphatase activity
through the switch helices.
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Hab1
The PP2C phosphatase Hab1 is a member of a sub-family of related phosphatases that regulate
drought tolerance in response to abscisic acid in plants (Ma et al., 2009; Park et al., 2009) (Fig-
ure 5—figure supplement 4A). It is the only PP2C phosphatase for which a structure bound to its
protein substrate (the kinase SnRK2) is available (Soon et al., 2012). Hab1 contacts SnRK2 primarily
through a sub-domain (termed the ‘flap’ [Pullen et al., 2004]) that is variable in PP2C phosphatases
and that packs against the switch helices (blue in Figure 5—figure supplement 4B and C)
(Soon et al., 2012). In the presence of abscisic acid, the PYR/PYL/RCAR family of abscisic-acid-bind-
ing proteins inhibit Hab1 by binding to a site that overlaps with the binding site for SnRK2, suggest-
ing that the switch could be influenced both by substrate and regulator binding. This could be a
more general feature of PP2C phosphatases; the corresponding substrate-binding domain in SpoIIE
changed conformation upon SpoIIE dimerization and activation (Figure 5—figure supplement 4D),
suggesting that the conformational change of the switch could couple regulatory inputs to substrate
Figure 5. Evidence that the switch mechanism is broadly conserved among phosphatases. The structure of the
active SpoIIE457–827 phosphatase domain is shown in the center. The SpoIIE dimerization interface that mediates
activation is indicated with an orange arc. Similarly, additional arcs indicate regions where regulatory inputs
impinge on the PP2C phosphatase domain for RsbP (brown, Figure 5—figure supplement 1), Pdp1
(phosphorylation is shown in red, and lipoyl binding is shown in teal, Figure 5—figure supplement 2), Fem-2
(blue, Figure 5—figure supplement 3), Hab1 (grey, Figure 5—figure supplement 4), and RssB (green,
Figure 5—figure supplement 5). The diagram is based on structures illustrated in Figure 5—figure supplements
1–5.
DOI: 10.7554/eLife.26111.018
The following figure supplements are available for figure 5:
Figure supplement 1. Gain-of-function bypass suppressors suggest that the switch controls the energy stress
response PP2C phosphatase RsbP.
DOI: 10.7554/eLife.26111.019
Figure supplement 2. Structural evidence that the switch is used to control pyruvate dehydrogenase
phosphatase.
DOI: 10.7554/eLife.26111.020
Figure supplement 3. Structural evidence that the switch is used to control the sex-determining PP2C
phosphatase FEM-2.
DOI: 10.7554/eLife.26111.021
Figure supplement 4. The switch for the drought responsive PP2C phosphatase Hab1 switch could coordinate
phosphatase activity and substrate binding.
DOI: 10.7554/eLife.26111.022
Figure supplement 5. The switch for the pseudo-PP2C phosphatase RssB controls protease adapter activity.
DOI: 10.7554/eLife.26111.023
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binding. Additionally, coupling between substrate binding and the active conformation of the switch
helices would provide a conserved mechanism to achieve the known high substrate specificity of
PP2C phosphatases.
RssB
RssB activates the general stress response in E. coli, P. aeruginosa, and certain other gamma proteo-
bacteria (Battesti et al., 2011). Although RssB is closely related to PP2C phosphatases, its primary
role is not as a phosphatase (and does not require phosphatase activity), but rather as an adapter
protein, delivering the transcription factor sS for degradation by ClpXP in the absence of stress (Fig-
ure 5—figure supplement 5A). Structural and genetic studies revealed that adapter activity is regu-
lated by contacts between the RssB regulatory domain and the switch helices that are mediated by
dimerization, similar to our observations for SpoIIE (Battesti et al., 2013; Levchenko et al., 2009)
(Figure 5—figure supplement 5B and C). Because the primary function of an adapter protein is to
mediate protein-protein interactions, we hypothesize that for RssB the switch couples regulatory
inputs to substrate binding (rather than to phosphatase activity) through a mechanism such as pro-
posed above for Hab1. Thus, the switch mechanism may not only provide a flexible platform for
adapting phosphatase activity to various inputs but also to control different outputs. We note that
there are other pseudo-PP2C phosphatases including Tab1, which mediates caspase dependent
apoptosis (Lu et al., 2007) and which may have similarly repurposed the switch mechanism.
Based on these examples, we conclude that the SpoIIE regulatory switch is broadly used to con-
trol diverse PP2C phosphatases via regulatory domains that dock on the switch to couple phospha-
tase activity to regulatory inputs (Figure 5).
The PP2C switch is shared with the proteasome proteases
One of the most striking discoveries of our investigation is that the PP2C regulatory switch strongly
resembles the allosteric switch that regulates the family of proteases that form the catalytic core of
the proteasome (Arciniega et al., 2014; Ruschak and Kay, 2012; Shi and Kay, 2014; Sousa et al.,
2000). These proteases are the most structurally similar family to PP2C phosphatases as revealed
using the DALI server (Holm and Rosenstro¨m, 2010) and the ECOD database (Cheng et al., 2014),
and like PP2C phosphatases their catalytic activity is subject to allosteric regulation. Specifically, the
proteasome proteases and PP2C phosphatases have a conserved core fold (Figure 6A and B), which
includes the switch helices, and the active sites are positioned in the same overall part of the struc-
ture. Although the proteases use different functional groups to mediate catalysis, the carbonyl oxy-
gen of a conserved glycine (G629 of SpoIIE) at the junction of the core domain and the switch
helices is used by both enzyme families for catalytic activity (Sousa et al., 2000).
Association with the regulatory cap activates the proteases, ensuring that the proteolytic active
sites are sequestered prior to activation (Seol et al., 1997) (Figure 6C). Early studies on HslV, the E.
coli homologue of the proteasome proteases, revealed that allosteric activation by the HslU cap
takes place by rotation of the switch helices to position the active site glycine (Figure 6D)
(Sousa et al., 2000). This mechanism is remarkably similar to the regulatory mechanism we pro-
posed for PP2C phosphatases; docking of a regulatory module repositions the structurally homolo-
gous region in the same way to position the same functional group to achieve catalytic activity
(Video 2).
This mechanism is also conserved for the archaeal proteasome, which like the eukaryotic protea-
some includes an additional layer of related, but catalytically inactive a subunits; docking of the cap
displaces the switch helices of the a subunits, which directly contact and reposition the switch helices
of the catalytic b subunits (Ruschak and Kay, 2012). Several lines of evidence suggest that this
mechanism is conserved for the eukaryotic proteasome (Arciniega et al., 2014) and is additionally
used by chaperones that promote proteasome maturation (Wani et al., 2015). Finally, comparative
studies of the constitutive proteasome and the immune proteasome suggested that differences in
the conformational flexibility of the switch underlies their differences in activity (Arciniega et al.,
2014).
Thus, our identification of the PP2C switch demonstrates that PP2C phosphatases and the protea-
some use the same allosteric regulatory module, revealing an unexpected link between two funda-
mental signaling systems – reversible phosphorylation and regulated proteolysis. Independent
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analysis of structural and sequence similarity suggest that this is a result of common evolutionary
ancestry. Structural comparison by the ECOD database, which classifies the evolutionary relation-
ships of protein folds places PP2C phosphatases and the proteasome proteases in the same ‘X-
group’, which is consistent with homology (Cheng et al., 2014). Independently, sequence-based
searches using HHPRED (So¨ding et al., 2005) detected weak sequence similarity between phospha-
tases and the broad family of NTN-hydrolases that includes the proteasome proteases. For example,
using the SpoIIE phosphatase domain sequence to search hidden Markov model alignments for B.
subtilis proteins identified weak sequence similarity to D-fructose-6-phosphate amidotransferase, an
NTN hydrolase. Notably, the region of possible sequence similarity maps to the switch helices and
the b strands that follow and pack with the switch (although it is not known whether the switch heli-
ces play a regulatory role in amidotransferases).
Allostery as a potential driver of evolutionary innovation
What evolutionary path might connect proteasomal proteases and PP2C phosphatases? Acquisition
of a new catalytic mechanism requires that the ancestral protein retain function while acquiring the
changes necessary for the new catalytic mechanism. However, conversion between the catalytic
mechanisms of the proteasomal proteases and PP2C phosphatases would require multiple changes
that would individually inactivate both activities (including circular permutation of the enzyme, loss/
Figure 6. The switch mechanism is shared with proteasome proteases. A is a secondary structure topology diagram for SpoIIE (left) and for HslV (the E.
coli homolog of the proteasome protease; right). b strands are shown as arrows pointing from N to C terminus and a-helices as circles in cross section.
Conserved features are dark grey, whereas variable features are light grey. The conserved glycine that moves to activate each protein is indicated with
a red circle. The switch helices of SpoIIE and the corresponding a-helices of HslV are colored orange. B shows ribbon diagrams of SpoIIE and HslV
(PDB ID 1G3I) colored as in A. The position of the conserved regulatory glycine (G649 in SpoIIE, and G69 in HslV) is shown with a red sphere and the
insertions specific to each protein are indicated by brackets. C is a schematic of how the regulatory particle (blue) activates the proteasome proteases
(grey). D shows an overlay of the active (PDB ID 1G3I) and inactive (PDB ID 1G3K) states of HslV following superimposition of the regions in grey. The
switch helices are color-coded orange and light orange for the active and inactive states, respectively. The active site residues T1, K33, and the carbonyl
oxygen of G69 are shown.
DOI: 10.7554/eLife.26111.024
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gain of metal binding, and charge swaps of resi-
dues at essential positions for catalysis). The con-
servation of the allosteric regulatory switch
suggests a possible solution to this dilemma:
namely, that the intermediate was a noncatalytic
pseudoenzyme that retained the allosteric regula-
tory switch. RssB is an example of this sort of
hypothetical pseudoenzyme; RssB uses the PP2C
switch to regulate protease adapter function
without functioning as a phosphatase
(Battesti et al., 2013). An RssB-like intermediate
would provide evolutionary pressure to preserve
the regulatory mechanism, while creating a con-
dition of neutrality to other mutations that would
allow the new chemistry to evolve. Indeed, E. coli
RssB lacks the C-terminal b strand of PP2C phos-
phatases that is substituted by the N-terminus of
the proteases (Figure 6A), suggesting a pathway
for how a gene fusion event could produce the
topological change required to evolve protease
activity.
Allosteric regulatory modules have facilitated
the evolutionary diversification of enzyme families
to respond to new regulatory inputs, and the reg-
ulatory mechanism we have described for PP2C
phosphatases may have similarly facilitated phosphatase diversification. A recent investigation of the
evolution of ligand specificity in PDZ domains proposed that allostery produces conformational flexi-
bility and thus may arise as a consequence of evolutionary history (Raman et al., 2016). Here we
propose a mechanism whereby pre-existing allosteric regulatory modules such as we have identified
for PP2C phosphatases facilitated the evolution of new enzymatic activities by transition through a
pseudoenzyme intermediate that is pre-programmed for regulation. Pseudoenzymes are abundant
(for example, 10% of kinase family members are pseudoenzymes) (Leslie, 2013) and thus may be
important for their evolutionary potential in addition to their current biological functions.
Materials and methods
Construct design
The SpoIIE457–827 construct was designed based on a putative sub-domain immediately N-terminal
to the conserved PP2C phosphatase domain that we identified using HHPRED RRID:SCR_010276
(So¨ding et al., 2005). This region exhibited weak similarity to several proteins including another
sporulation protein SpoIIIAH. Analysis of the regulatory domain (the newly determined portion of
the structure) using the DALI server RRID:SCR_013433 (Holm and Rosenstro¨m, 2010) identified sim-
ilarity to GpsL, a component of the type II secretion system, and structural alignment of the regula-
tory domain with SpoIIIAH matched the alignment predicted by HHPRED (So¨ding et al., 2005).
Protein expression and purification
The SpoIIE457–827 coding sequence was inserted into pET47b vector that had been digested with
XmaI and XhoI using isothermal assembly. SpoIIE amino acid residue substitutions were introduced
to this construct by Quikchange site directed mutagenesis. These constructs were introduced to E.
coli BL21 (DE3) cells for protein expression. Cells were grown at room temperature to an OD600 of
0.4, then were shifted to 14˚C and expression was induced for 14–18 hr with 1 mM IPTG. Cells were
harvested and pellets were resuspended in 5 ml/L of cell culture of 50 mM K.HEPES pH 8, 200 mM
NaCl, 20 mM Imidazole, 10% Glycerol, 0.5 mM DTT, and 1 mM PMSF. Cells were lysed using a cell
disruptor in one-shot mode (Constant Systems, Daventry, United Kingdom) and lysates were clarified
by spinning for 30 min at 16,000 RPM in a Sorvall SS-34 rotor at 4˚C. Lysates were loaded to a
Video 2. PP2C phosphatases and proteasomal
proteases share a common conformational switch.
Shown are side-by-side displays of SpoIIE and HslV
morphing from the inactive to active states. Shown on
the left is the PP2C phosphatase domain of SpoIIE
morphing from SpoIIE590–827 (inactive, PDB ID 5MQH)
to SpoIIE457–827 (active, PDB ID 5UCG) as in Figure 3B.
Shown on the right is HslV morphing from the HslU
free structure (inactive, PDB ID 1G3K) to the HslU
bound structure (active, PDB ID 1G3I) as in Figure 6D.
The switch helices are colored orange and the active
site residues of each protein are shown.
DOI: 10.7554/eLife.26111.025
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HisTrap-HP column on an AKTA FPLC and eluted with a gradient of imidazole to 200 mM. The 6His
tag was cleaved overnight with PreScission protease during dialysis to 50 mM K.HEPES pH 8, 200
mM NaCl, 20 mM Imidazole, 10% Glycerol, 0.5 mM DTT at 4˚C. The PreScission protease was
removed by flowing the dialyzed protein over a Ni-NTA resin, and the flowthrough was loaded to a
Resource Q column that had been pre-equilibrated in 50 mM K.HEPES pH 8, 100 mM NaCl, 2 mM
EDTA, 2 mM DTT. Protein was eluted using a gradient to 500 mM NaCl. Fractions containing SpoIIE
were concentrated on Amicon Ultra centrifugal filters and loaded to a Superdex 200 column equili-
brated with 20 mM K.HEPES pH 8, 50 mM NaCl, 2 mM DTT. Fractions containing SpoIIE were con-
centrated and immediately used to set up crystallization trials or were flash frozen in liquid nitrogen
after addition of 10% glycerol.
Seleno-Methionine derivatized SpoIIE457–827 protein was grown in fully supplemented M9 media.
Fifteen minutes before induction, 100 mg/L L-Phenylalanine, 50 mg/L L-Isoleucine, 100 mg/L
L-Lysine, 50 mg/L L-Leucine, 100 mg/L L-Threonine, 50 mg/L L-Valine, and 60 mg/L L-Selenomethio-
nine were added. Otherwise induction and purification were identical to the un-derivatized protein.
Recombinant SpoIIE590–827 (with an amino acid substitution A624I that was designed to block
domain swapping) was overproduced from E. coli BL21 (DE3) harboring a pET-YSBLIC derivative
plasmid. Cultures were grown at 37˚C and induced at OD600 = 0.6–0.7 by addition of IPTG to 1 mM
followed by overnight growth at 16˚C. Cells were harvested and the pellets resuspended in 20 mM
sodium phosphate (pH 7.5), 0.5 M NaCl, 20 mM imidazole (Buffer A). The supernatant was loaded
onto a HiTrap Ni-NTA column equilibrated with buffer A and eluted with a 20–500 mM imidazole
gradient in buffer A. Fractions containing SpoIIE were concentrated before loading on to a Superdex
S200 column equilibrated with 20 mM Tris pH 8.5, 150 mM NaCl.
X-ray structure determination
SpoIIE457–827 crystals were grown in sitting drops using Swissci 3 well 96 well plates (Hampton, Aliso
Viejo, CA) with 40 ml well solution (0.5 mM LiSO4, 8% PEG8000, 0.05 mM NaF, 6% glycerol).
SpoIIE457–827 (11 mg/mL) in 20 mM K.HEPES pH 8, 50 mM NaCl, 2 mM DTT was supplemented with
0.05 mM NaF and mixed at a 2:1 ratio with well solution in 300 nL drops using an NT8 robot
(Formulatrix, Bedford, MA). Crystals grew over two weeks at room temperature. Crystals were cryo-
protected by serial transfer to well solution supplemented with 10% and then 15% glycerol and
plunged in liquid nitrogen. Data were collected at the Advanced Photon Source at Argonne National
Laboratory on NE-CAT beamlines 24ID-C and 24ID-E.
Data were processed using HKL-2000 (Otwinowski and Minor, 1997) and initial phases were
determined by molecular replacement using MR-PHASER RRID:SCR_014219 (McCoy et al., 2007)
and an unswapped model from the published structure of SpoIIE590–827 as the search model
(Levdikov et al., 2012). Iterative model building and refinement was done in COOT RRID:SCR_
014222 (Emsley et al., 2010) and refinement in PHENIX RRID:SCR_014224 (Adams et al., 2010).
Non-crystallographic symmetry was initially enforced for the five chains in the asymmetric unit, then
released first for chain B and finally for all chains. In later stages of refinement NCS was again
imposed on regions where the chains differed by less than 4 A˚. Model restraints were used based
on the structure of SpoIIE590–827 published here during an intermediate stage of refinement.
The model for SpoIIE457–827 was additionally validated using anomalous signal from crystals
grown with seleno-methionine derivatized protein (Table 2). With the exception of M557, signals
were observed for all methionines at the expected sites in the anomalous difference map (an exam-
ple is shown in Figure 1—figure supplement 1A).
Crystallization experiments with SpoIIE590–827 consistently led to crystals of the domain-swapped
dimeric form of the protein, even though SEC-MALLS analysis showed that SpoIIE590–827 is predomi-
nantly monomeric (Levdikov et al., 2012). To stabilize the PP2C domain and slow down/prevent
domain-swapping during crystallization, we introduced residue substitutions to reinforce the inter-
face involved in domain-swapping. One such SpoIIE590–827 mutant, A624I, constructed by Quik-
change mutagenesis (changing the GCA codon to ATA), led to the crystallization of SpoIIE590–827
without domain swapping. Residues with bulkier aliphatic side-chains (L, I, V or M) are found at the
position corresponding to A624 in many SpoIIE orthologues.
Crystals of SpoIIE590–827(A624I) were grown from hanging drops formed by mixing 1 ml of 38 mg/
mL protein with 1 mL of 2 M sodium formate, 100 mM sodium acetate, pH 4.6. The crystals were
cryo-protected in mother liquor containing 4 M sodium formate for X-ray data collection on
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beamline I02 at the DIAMOND Light Source. Data extending to 2.44 A˚ spacing were collected and
processed using HKL-2000 (Otwinowski and Minor, 1997). Initial phases were determined by
molecular replacement using MOLREP (Vagin and Teplyakov, 2010), and a coordinate set derived
Table 3. Table of strains. B. subtilis strains (all strains are in the background of PY79-RL3).
Strain # Genotype Reference
RL3 prototrophic Youngman et al., 1984
RL5874 spoIIE::kan yxiD::spoIIE-yfp spc amyE::PspoIIE-cfp cm Bradshaw and Losick, 2015
RL5902 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp L646K spc Bradshaw and Losick, 2015
RL5904 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp Q483A spc Bradshaw and Losick, 2015
RL5905 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp G486K spc Bradshaw and Losick, 2015
RL5907 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp E639K spc Bradshaw and Losick, 2015
RL6198 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp V480K spc this study
RL6199 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp A481K spc this study
RL6200 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp L484K spc this study
RL6201 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp V487K spc this study
RL6202 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp S488K spc this study
RL6203 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp V490K spc this study
RL6204 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp M491K spc this study
RL6205 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp D493K spc this study
RL6206 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp F494K spc this study
RL6207 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp S495K spc this study
RL6208 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp E497K spc this study
RL6209 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp I498K spc this study
RL6210 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp E642K spc this study
RL6211 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp I650K spc this study
RL6212 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp T663K spc this study
RL6213 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-yfp I667K spc this study
RL5915 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-Dtag-yfp L646K spc Bradshaw and Losick, 2015
RL6246 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-Dtag-yfp V480K spc this study
RL6247 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-Dtag-yfp L484K spc this study
RL6248 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-Dtag-yfp V487K spc this study
RL6249 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-Dtag-yfp F494K spc this study
RL6250 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-Dtag-yfp I498K spc this study
RL6251 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-Dtag-yfp I650K spc this study
RL6252 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-Dtag-yfp T663K spc this study
RL6253 spoIIE::kan yhdGH::PspoIIQ-cfp tet amyE::spoIIE-Dtag-yfp M491K spc this study
E. coli strains
RL6214 BL21 (DE3) pET47b H6-3C-spoIIE 457–827 This study
RL6215 BL21 (DE3) pET47b H6-3C-spoIIE 457–827 V697A this study
RL6216 BL21 (DE3) pET47b H6-3C-spoIIE 457–827 D628A this study
RL6217 BL21 (DE3) pET47b H6-3C-spoIIE 457–827 L484K this study
RL6218 BL21 (DE3) pET23a H6-sumo-spoIIAA Bradshaw and Losick, 2015
RL6219 BL21 (DE3) pET23a H6-sumo-spoIIAB Bradshaw and Losick, 2015
AW2001 BL21 (DE3) pET-YSBLIC H6-3C-spoIIE 590–827 A624I Levdikov et al., 2012
AW2002 BL21 (DE3) pET-YSBLIC H6-3C-spoIIAA spoIIAB Levdikov et al., 2012
DOI: 10.7554/eLife.26111.026
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from PDB ID 3T91 as the search model. The structure was rebuilt and refined using iterative cycles
of COOT RRID:SCR_014222 (Emsley et al., 2010) and REFMAC RRID:SCR_014225
(Murshudov et al., 1997) respectively. Data collection and refinement statistics are given in Table 1.
SEC-MALLS
SEC-MALLS was performed by loading 100 mL of 200 mM SpoIIE457–827 to a Wyatt WTC-030S5 col-
umn using an Agilent HPLC in line with Wyatt DAWN-HELIOS and Optilab rEX detectors. Before run-
ning SpoIIE457–827 was exchanged to 25 mM K.HEPES pH 8, 100 mM NaCl using a Superdex 200
column. The SEC-MALLS instrument was equilibrated in 25 mM K.HEPES pH 8, 100 mM NaCl, sup-
plemented with MnCl2 as appropriate. SpoIIE
457–827 samples were supplemented with MnCl2 shortly
before running on the SEC-MALLS. Analysis was conducted using the ASTRA software. All SEC-
MALLS samples were run in at least triplicate. SEC experiments shown in Figure 4—figure supple-
ment 1 were conducted similarly, loading 200 mL of 200 mM SpoIIE457–827 on a 20 mL Superdex 200
column on an AKTA FPLC.
Phosphatase assays
Phosphatase assays were performed as reported in Bradshaw and Losick, 2015. SpoIIAA, SpoIIAA-
P, and SpoIIAB were produced and purified as described previously. SpoIIAA-P was produced by
overexpression of 6H-SpoIIAA in an E. coli strain that also expressed SpoIIAB (Levdikov et al.,
2012). To produce 32P labeled SpoIIAA-P, 75 mM SpoIIAA, 5 mM SpoIIAB and 50 mCi of g-32P ATP
were incubated overnight in 50 mM K.HEPES pH 7.5, 50 mM KCl, 750 mM MgCl2, 2 mM DTT. The
protein was exchanged to 20 mM K.HEPES pH 7.5, 200 mM NaCl, 2 mM DTT over a Zeba spin col-
umn (Pierce) to remove unincorporated nucleotide and then flowed over Q sepharose resin to
remove SpoIIAB. Phosphatase assays were performed in 25 mM K.HEPES pH 8, 100 mM NaCl, 100
mg/ml BSA (supplemented with MnCl2 as appropriate) with 2.5 mM SpoIIE and 200 mM SpoIIAA-P.
Reactions were started by adding SpoIIE to a mixture containing SpoIIAA-P and MnCl2. Reactions
were stopped in 1 M KPO4 pH 3.3, 2% Triton X-100 and run on PEI-Cellulose TLC plates developed
in 1 M LiCl2, 0.8 M Acetic Acid, and imaged on a Typhoon (GE Life Sciences, Pittsburgh, PA). Phos-
phatase assays were performed more than three independent times as separate experiments.
B. subtilis strains and analysis
B. subtilis strains were constructed using standard molecular genetic techniques (Harwood and Cut-
ting, 2010) in the PY79 strain background (Youngman et al., 1984; Zeigler et al., 2008) and were
validated to contain the correct constructs by double-crossover recombination at the correct inser-
tion site. All strains used in this study are described in Table 3. For imaging, cells were grown at
37˚C in 25% LB to OD 0.6, resuspended in minimal sporulation resuspension medium, and grown for
2.5 hr. Cells were immobilized on 2.5% agarose pads made with the sporulation resuspension
medium and imaged on an Olympus BX-61 upright microscope with a 100X objective. Cells were
segmented using SuperSegger (Stylianidou et al., 2016) and analyzed with custom MatLab scripts
(Bradshaw and Losick, 2015). Samples were taken from the same cultures for western blot analysis;
cells were lysed using a FastPrep (MP-BIO, Santa Ana, CA) and blots were probed with polyclonal a-
GFP antibody.
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